State of Wisconsin Investment Board’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

State of Wisconsin Investment Board’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,900	Closed	-$36K	–	2940
2022 Q1	$36K	Sell	21,900 -14,700	-40%	-$26.2K	﹤0.01%	2238
2021 Q4	$87K	Sell	36,600 -10,100	-22%	-$41.1K	﹤0.01%	2121
2021 Q3	$255K	Buy	46,700 +4,900	+12%	+$30.4K	﹤0.01%	2030
2021 Q2	$311K	Buy	41,800 +1,800	+5%	+$12.8K	﹤0.01%	1920
2021 Q1	$324K	Buy	40,000 +23,600	+144%	+$257K	﹤0.01%	1815
2020 Q4	$149K	Buy	+16,400	New	+$135K	﹤0.01%	1967

Other funds holding KLDO

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

State of Wisconsin Investment Board's KLDO Position: Q2 2022 in Review

State of Wisconsin Investment Board sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 21,900 shares — an estimated $36K sold.

State of Wisconsin Investment Board first reported a position in KLDO in Q4 2020 and held it in 6 quarters. The position peaked at $324K in Q1 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

State of Wisconsin Investment Board reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
State of Wisconsin Investment Board sold 21,900 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $36K.
State of Wisconsin Investment Board first reported a position in Kaleido Biosciences, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
State of Wisconsin Investment Board's Kaleido Biosciences, Inc. Common Stock position peaked at $324K in Q1 2021.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2022, filed 15 Aug 2022.